Transgene Biotek Performance
- Today's Low
- ₹3
- Today's High
- ₹3
- 52 Week Low
- ₹2
- 52 Week High
- ₹5
- Open Price₹3
- Previous Close₹3
- Volume2,461
- 50 DMA₹3.00
- 100 DMA₹3.00
- 200 DMA₹3.20
Transgene Biotek Chart
Investment Returns
- Over 1 Month -3.86%
- Over 3 Month + 4.91%
- Over 6 Month + 22.54%
- Over 1 Year -37.71%
Smart Investing Starts Here Start SIP with Transgene Biotek for Steady Growth!
Transgene Biotek Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -13.7
- PEG Ratio
- 0.1
- Market Cap Cr
- 23
- P/B Ratio
- 2.7
- Average True Range
- 0.2
- EPS
- -0.2
- Dividend Yield
- 0
- MACD Signal
- -
- RSI
- 50.12
- MFI
- 28.28
Latest Stock News Updates
Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby infom you that a meeting of the Board of Directors of Transgene Biotek Limited is scheduled to be held on Friday, August 07, 2026, inter alia, to consider and approve the following matters: 1. To consider and approve the n-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2026. 2. To consider and approve the Limited Review Report (Standalone & Consolidated) of the Company for the quarter ended 30h June 2026. 3. To consider and approve seeking an extension of time for holding the Annual General Meeting (AGM) of the Company for the Financial Year 2025-26. 4. To consider and approve the appointment of the internal auditor of the Company for financial year 2026-27. 5. To transact such other business as may be required.
- BSE India
- 3 days 19 hours ago
Compliance - 57(4)
- BSE India
- 4 days 22 hours ago
Statement of Deviation & Variation
- BSE India
- 4 days 22 hours ago
Transgene Biotek Financials
Transgene Biotek Technicals
EMA & SMA
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹3.00
- 50 Day
- ₹3.00
- 100 Day
- ₹3.00
- 200 Day
- ₹3.20
Resistance and Support
- R3 3.30
- R2 3.20
- R1 3.10
- S1 2.90
- S2 2.80
- S3 2.80
Transgene Biotek Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-07 | Quarterly Results & Others | |
| 2026-05-29 | Audited Results | |
| 2026-02-13 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-08-07 | Quarterly Results |
About Transgene Biotek
Transgene Biotek is an Indian public biotech firm, established in 1990, focused on R&D for vaccines, oncology, biogenerics, and novel drug delivery (oral/nasal proteins/peptides) for unmet needs, exporting to various global markets and developing treatments for cancer, auto-immune issues, etc View More- NSE Symbol
- TRABI
- BSE Symbol
- 526139
- ISIN
- INE773D01018
Similar Stocks to Transgene Biotek
Popular Stocks
Transgene Biotek FAQs
Transgene Biotek share price is ₹2 As on 27 July, 2026 | 12:24
The Market Cap of Transgene Biotek is ₹22.7 Cr As on 27 July, 2026 | 12:24
The P/E ratio of Transgene Biotek is -13.7 As on 27 July, 2026 | 12:24
The PB ratio of Transgene Biotek is 2.7 As on 27 July, 2026 | 12:24
The 52 week High & Low of Transgene Biotek is ₹5.2/₹1.8 respectively As on 27 July, 2026 | 12:24
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.